24.03.2022 Views

Oncology Drugs Market Size Is Developing Rapidly Worth $436.76 Billion By 2028

The global oncology drugs market size is expected to reach USD 436.76 billion by 2028, according to a new report by Million Insights. It is expected to expand at a CAGR of 12.0% from 2021 to 2028.

The global oncology drugs market size is expected to reach USD 436.76 billion by 2028, according to a new report by Million Insights. It is expected to expand at a CAGR of 12.0% from 2021 to 2028.

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Oncology Drugs Market Size Is Developing

Rapidly Worth $436.76 Billion By 2028

“The global oncology drugs market size is expected to reach USD 436.76 billion by 2028.

It is expected to expand at a CAGR of 12.0% from 2021 to 2028. The market is expected

to witness growth due to the rising prevalence of cancer, availability of medical

resources for detecting and treating cancer patients, increasing pollution levels, and

changing lifestyles.

The global oncology drugs market size is expected to reach USD 436.76 billion by 2028. It is expected to expand at a

CAGR of 12.0% from 2021 to 2028. The market is expected to witness growth due to the rising prevalence of cancer,

availability of medical resources for detecting and treating cancer patients, increasing pollution levels, and changing

lifestyles. Additionally, the rising per capita income and the increasing purchasing power are other significant factors

driving the growth of the market.

The prostate segment is expected to register the second-fastest CAGR of 13.5% from 2021 to 2028. Prostate cancer is

the second leading cause of cancer-related deaths among men. Obesity and consumption of foods with high calcium

levels are some of the major factors leading to prostate cancer. Genetic mutation is also a major factor causing prostate

cancer. Growing awareness about the disease is contributing to various treatments and related drugs. Thus, the market

is expected to witness increasing revenue from prostate drugs during the forecast period.

North America held the largest revenue share of more than 40% in 2020. The U.S. is positively contributing to the

growth of the regional market. The presence of well-established pharmaceutical vendors is one of the key factors

supporting the growth. North America is one of the promising regions to launch new technology in terms of well

healthcare infrastructure and advanced research and development activities that help innovate and produce the most

appropriate drugs to cure cancer. Additionally, ease of availability of drugs and reimbursement policies for the patients

in the healthcare industry are contributing to revenue generation.

Request Sample Copy of This Market Research @

https://www.millioninsights.com/snapshots/oncology-drugs-market-report/request-demo


Oncology Drugs Market Report Highlights

• North America held the largest revenue share of more than 40% in 2020. The presence of well-established

pharmaceutical vendors is one of the key factors supporting the growth of the regional market

• The prostate segment is expected to register the second-fastest CAGR of 13.5% from 2021 to 2028. Growing

awareness about prostate cancer is contributing to various treatments and related drugs

• The breast segment is likely to expand at the highest CAGR of 13.8% from 2021 to 2028, due to the rising

prevalence and awareness regarding breast cancer

Oncology Drugs Market Segmentation

Million Insights has segmented the global oncology drugs market based on indication and region:

• Oncology Drugs Indication Outlook (Revenue, USD Million, 2017 - 2028)

• Lung

• Breast

• Colorectal

• Prostate

• Stomach

• Liver

• Others

• Oncology Drugs Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America

• U.S.

• Europe

• Germany

• France


• U.K.

• Asia Pacific

• China

• Japan

• Central & South America

• Brazil

• Middle East & Africa

• South Africa

List of Key Players of the Oncology Drugs Market

• Merck

• Novartis

• JOHNSON & JOHNSON

• Pfizer

• AstraZeneca

• Eli Lilly

• Hoffmann-La Roche

• AbbVie

• Sanofi

• GSK

Browse Full Research Report @

https://www.millioninsights.com/snapshots/oncology-drugs-market-report


Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction.

Our representatives strive to understand diverse client requirements and cater to the same with

the most innovative and functional solutions.

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email: ryan@millioninsights.com

Global Headquarters

Million Insights

410 E Santa Clara Street, Unit #1008 San Jose, CA 95113, United States

Phone: 1-408-610-2300

Email: sales@millioninsights.com

Asia Pacific

Million Insights

Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016

India

Phone: 91-8956380892

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!